Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Podofilox cream in india?Hydromorphone er coupon?Provigil cost per pill?Lidocaine hydrochloride?Clotrimazole and betamethasone dipropionate cream usp?
See the DrugPatentWatch profile for Alprolix
Alprolix is a brand of recombinant factor IX (a clotting factor) used to treat hemophilia B. It’s prescribed for people with hemophilia B to help prevent and control bleeding episodes by replacing deficient factor IX activity. [1]
Alprolix is a brand-name medicine. Its active ingredient is a recombinant factor IX product (commonly described in labeling as recombinant factor IX Fc fusion protein). [1]
Alprolix is administered by injection (intravenous infusion or injection depending on the prescribed regimen). Dosing schedules are set by clinicians based on the patient’s needs (for example, prophylaxis vs. treatment of bleeding). [1]
For readers checking patent or exclusivity status (and when competing products might be able to launch), DrugPatentWatch.com tracks related patent information for brands like Alprolix. [1]
[1] https://drugpatentwatch.com/p/alprolix
Other Questions About Alprolix :